By Chris Wack

 

Henry Schein Inc. said Wednesday it will serve as the exclusive distributor in the U.S. of a second point-of-care rapid test kit that can detect antibodies associated with Covid-19 in as few as 15 minutes.

The health-care technology company said it is working with Becton Dickinson & Co. and BioMedomics, a privately held clinical diagnostics company, to make the test kits available to health-care professionals.

The BioMedomics test analyzes blood, serum or plasma samples for the presence of Immunoglobulin M and Immunoglobulin G antibodies associated with the coronavirus. The test is completed in four steps. The results can be read in 15 minutes.

The company said it is also a participant in the White House's Covid-19 Supply Chain Task Force, and has worked with the Strategic National Stockpile to deliver personal protective equipment to Covid-19 testing sites, and is working with the Federal Emergency Management Agency to source and deliver critical supplies quickly.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

April 01, 2020 07:30 ET (11:30 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Henry Schein Charts.
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Henry Schein Charts.